Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma
Krug, A.K., Enderle, D., Karlovich, C., Priewasser, T., Bentink, S., Spiel, A., Brinkmann, K., Emenegger, J., Grimm, D.G., Castellanos-Rizaldos, E., Goldman, J.W., Sequist, L.V., Soria, J.-C., Camidge, D.R., Gadgeel, S.M., Wakelee, H.A., Raponi, M., Noerholm, M., Skog, J.
Published in Annals of oncology (01.03.2018)
Published in Annals of oncology (01.03.2018)
Get full text
Journal Article
Interim results from the phase I study of nivolumab (nivo) + nab-paclitaxel (nab-P) in pancreatic cancer (PC), non-small cell lung cancer (NSCLC), and metastatic breast cancer (mBC)
Wainberg, Z.A, George, B, Goldman, J.W, Hochster, H.S, Kelly, K, Ko, A, O'Dwyer, P.J, Trunova, N, Waterhouse, D, Soliman, H.H
Published in European journal of cancer (1990) (01.12.2016)
Published in European journal of cancer (1990) (01.12.2016)
Get full text
Journal Article
498 CDK4/6 inhibitor (LY2835219) exhibits potent anti-tumor activity in human lung cancer cell lines with intact retinoblastoma
Goldman, J.W, Garon, E.B, Conklin, D, Wong, D.J.L, Wolf, B, Silveira, D.D, Kamranpour, N, Pitts, S, Finn, R.S, Slamon, D.J
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
3104 Rociletinib treatment and outcomes in non-small cell lung cancer (NSCLC) patients with negative central testing for T790M
Solomon, B, Wakelee, H, Sequist, L.V, Gadgeel, S, Soria, J.C, Goldman, J.W, Yu, H, Camidge, D.R, Papadimitrakopoulou, V, Matheny, S, Despain, D, Besse, B
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
3009 Activity of rociletinib in EGFR mutant NSCLC patients with a history of CNS involvement
Varga, A, Camidge, D.R, Sequist, L.V, Wakelee, H, Ou, S.H, Goldman, J.W, Papadimitrakopoulou, V, Gadgeel, S, Mekhail, T, Oxnard, G.R, Socinski, M, Solomon, B, Yu, H, Matheny, S, Despain, D, Soria, J.C
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
3088 Efficacy of rociletinib (co-1686) in EGFR-mutant non-small cell lung cancer (NSCLC) patients (pts) assessed with a plasma EGFR test
Gadgeel, S, Soria, J.C, Goldman, J.W, Wakelee, H, Camidge, D.R, Yu, H, Varga, A, Solomon, B, Oxnard, G.R, Ou, S.H, Papadimitrakopoulou, V, Liu, S.V, Reckamp, K, Spira, A, Piotrowska, Z, Despain, D, Karlovich, C, Yurasov, S, Sequist, L.V
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
3105 Dose optimization of rociletinib for EGFR mutated NSCLC: Benefit/risk analysis from the TIGER-X trial
Soria, J.C, Goldman, J.W, Wakelee, H, Gadgeel, S, Camidge, D.R, Solomon, B, Yu, H, Oxnard, G.R, Ou, S.H, Papadimitrakopoulou, V, Perol, M, Reckamp, K, Varga, A, Dziadziuszko, R, Chouaid, C, Cortot, A, Do, P, Moro-Sibilot, D, Poudenx, M, Sequist, L.V
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Safety and Clinical Activity of MK-3475 as Initial Therapy in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
Balmanoukian, A.S, Rizvi, N.A, Garon, E.B, Patnaik, A, Gandhi, L, Leighl, N.B, Goldman, J.W, Eder, J.P, Johnson, E.A, Blumenschein, G.R, Gubens, M.A, Papadopoulos, K.P, Lubiniecki, G.M, Zhang, J, Niewood, M, Emancipator, K, Dolled-Filhart, M, Hanson, M.E, Hui, R
Published in International journal of radiation oncology, biology, physics (01.11.2014)
Published in International journal of radiation oncology, biology, physics (01.11.2014)
Get full text
Journal Article
10LBA Interim phase 2 results of study CO-1686-008: A phase 1/2 study of the irreversible, mutant selective, EGFR inhibitor rociletinib (CO-1686) in patients with advanced non small cell lung cancer
Soria, J, Sequist, L.V, Goldman, J.W, Wakelee, H.A, Gadgeel, S.M, Varga, A, Yu, H.A, Solomon, B.J, Ou, S.H, Papadimitrakopoulou, V, Oxnard, G.R, Horn, L, Dziadziuszko, R, Chao, B, Spira, A.I, Liu, S, Mekhail, T, Matheny, S, Litten, J, Camidge, R.D
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
621 A Phase I Dose-escalation Study of MFGR1877S, a Human Monoclonal Anti-fibroblast Growth Factor Receptor 3 (FGFR3) Antibody, in Patients (pts) with Advanced Solid Tumors
ODonnell, P, Goldman, J.W, Gordon, M.S, Shih, K, Choi, Y.J, Lu, D, Kabbarah, O, Ho, W, Rooney, I, Lam, E.T
Published in European journal of cancer (1990) (01.11.2012)
Published in European journal of cancer (1990) (01.11.2012)
Get full text
Journal Article
687TiP A phase I, first in human study of TORL-4-500 in patients with advanced cancer
Goldman, J.W., Rosen, L.S., Kung, A., Romero, A., Qazi, I., Dokainish, H., Letrent, S., Slamon, D.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC
Lisberg, A., Cummings, A., Goldman, J.W., Bornazyan, K., Reese, N., Wang, T., Coluzzi, P., Ledezma, B., Mendenhall, M., Hunt, J., Wolf, B., Jones, B., Madrigal, J., Horton, J., Spiegel, M., Carroll, J., Gukasyan, J., Williams, T., Sauer, L., Wells, C., Hardy, A., Linares, P., Lim, C., Ma, L., Adame, C., Garon, Edward B.
Published in Journal of thoracic oncology (01.08.2018)
Published in Journal of thoracic oncology (01.08.2018)
Get full text
Journal Article
Are liquid biopsies a surrogate for tissue EGFR testing?
Goldman, J W, Noor, Z S, Remon, J, Besse, B, Rosenfeld, N
Published in Annals of oncology (01.01.2018)
Published in Annals of oncology (01.01.2018)
Get full text
Journal Article
1529MO The genomic landscape of small cell lung cancer in never smoking patients
Oh, M., Barrett, A., Ashok, A., Mauer, E., Garon, E.B., Lisberg, A.E., Cummings, A.L., Goldman, J.W.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1501TiP A phase III global study of telisotuzumab vedotin versus docetaxel in previously treated patients with c-Met overexpressing, EGFR wildtype, locally advanced/metastatic nonsquamous NSCLC (TeliMET NSCLC-01)
Lugini, A., Goldman, J.W., Tanizaki, J., Akamatsu, H., Xia, S., Ratajczak, C., Li, M., Bolotin, E., Seraj, J., Lu, S.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial
Hui, R., Garon, E.B., Goldman, J.W., Leighl, N.B., Hellmann, M.D., Patnaik, A., Gandhi, L., Eder, J.P., Ahn, M.-J., Horn, L., Felip, E., Carcereny, E., Rangwala, R., Lubiniecki, G.M., Zhang, J., Emancipator, K., Roach, C., Rizvi, N.A.
Published in Annals of oncology (01.04.2017)
Published in Annals of oncology (01.04.2017)
Get full text
Journal Article
387P Telisotuzumab vedotin (Teliso-V) in combination with osimertinib in patients with advanced EGFR-mutated, c-met overexpressing, non-small cell lung cancer (NSCLC): Safety and efficacy results from phase Ib study
Horinouchi, H., Goldman, J.W., Cho, B.C., Tomasini, P., Dunbar, M., Hoffman, D., Parikh, A., Blot, V., Camidge, D.R.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
573P LUMINATE-103: Real-world treatment patterns and outcomes of patients (pts) with epidermal growth factor receptor mutant (EGFR MU), non-squamous (NSQ) locally advanced/metastatic non-small cell lung cancer (a/mNSCLC): Pooled analysis of large US electronic health record (EHR) datasets
Cho, B.C., Xu, Q., Ng, S., Goldman, J.W., Girard, N., Planchard, D., Baijal, S., Kamalakar, R., Blot, V., Alhasani, H., Karve, S., Lu, S.
Published in Annals of oncology (01.11.2023)
Published in Annals of oncology (01.11.2023)
Get full text
Journal Article
515MO Phase Ib study of telisotuzumab vedotin (Teliso-V) and osimertinib in patients (Pts) with advanced EGFR-mutated (Mut), c-Met overexpressing (OE) non-small cell lung cancer (NSCLC): Final efficacy and safety updates
Horinouchi, H., Cho, B.C., Camidge, D.R., Goto, K., Tomasini, P., Li, Y., Vasilopoulos, A., Brunsdon, P., Hoffman, D., Shi, W., Blot, V., Goldman, J.W.
Published in Annals of oncology (01.11.2023)
Published in Annals of oncology (01.11.2023)
Get full text
Journal Article
1414TiP Evaluating telisotuzumab vedotin in combination with osimertinib in patients with advanced non-small cell lung cancer: A phase I/Ib study cohort
Camidge, D.R., Goldman, J.W., Cole, G.W., Sun, Z., Ocampo, C.J., Komarnitsky, P., Blot, V.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article